| # | Drug | Count |
|---|---|---|
| 0 | ASPIRIN | 23 |
| 1 | ASPIRIN 325 MG | 23 |
| 2 | ASPIRIN 81 MG | 23 |
| 3 | CLOPIDOGREL | 18 |
| 4 | ATORVASTATIN CALCIUM | 11 |
| 5 | LISINOPRIL | 11 |
| 6 | METOPROLOL TARTRATE | 7 |
| 7 | ADALIMUMAB | 6 |
| 8 | ALENDRONATE SODIUM | 6 |
| 9 | EVOLOCUMAB | 6 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | HYDRALAZINE HYDROCHLORIDE AND ISOSORBIDE DINITRATE | 1 | 0.0023 |
| 1 | CUPRIC CHLORIDE | 1 | 0.0013 |
| 2 | ALENDRONATE SODIUM AND CHOLECALCIFEROL | 2 | 0.0007 |
| 3 | GINKGO BILOBA | 1 | 0.0007 |
| 4 | GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE | 1 | 0.0005 |
| 5 | SAW PALMETTO | 1 | 0.0005 |
| 6 | LEBRIKIZUMAB-LBKZ | 1 | 0.0004 |
| 7 | SULINDAC | 1 | 0.0004 |
| 8 | CALCITONIN SALMON | 1 | 0.0003 |
| 9 | MARC GLASSMAN | 1 | 0.0003 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 26 |
| 1 | Platelet Aggregation Inhibitor [EPC] | 23 |
| 2 | Proton Pump Inhibitor [EPC] | 8 |
| 3 | Factor Xa Inhibitor [EPC] | 7 |
| 4 | Vitamin C [EPC] | 7 |
| 5 | beta-Adrenergic Blocker [EPC] | 7 |
| 6 | GLP-1 Receptor Agonist [EPC] | 6 |
| 7 | HMG-CoA Reductase Inhibitor [EPC] | 6 |
| 8 | PCSK9 Inhibitor [EPC] | 6 |
| 9 | Vitamin D [EPC] | 6 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Calcitonin [EPC] | 1 | 0.0003 |
| 1 | Carnitine Analog [EPC] | 1 | 0.0003 |
| 2 | PCSK9 Inhibitor [EPC] | 6 | 0.0002 |
| 3 | Interleukin-13 Antagonist [EPC] | 1 | 0.0001 |
| 4 | Thyroid Hormone Synthesis Inhibitor [EPC] | 1 | 0.0001 |
| 5 | Provitamin D2 Compound [EPC] | 3 | 0.0001 |
| 6 | Anti-anginal [EPC] | 1 | 0.0001 |
| 7 | Parenteral Iron Replacement [EPC] | 1 | 0.0001 |
| 8 | Influenza A M2 Protein Inhibitor [EPC] | 1 | 0.0001 |
| 9 | Soluble Guanylate Cyclase Stimulator [EPC] | 2 | 0.0001 |